Is Cytosorbents Crp Stock a Good Investment?
Cytosorbents Crp Investment Advice | CTSO |
- Examine Cytosorbents Crp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Cytosorbents Crp's leadership team and their track record. Good management can help Cytosorbents Crp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Cytosorbents Crp's business and its evolving consumer preferences.
- Compare Cytosorbents Crp's performance and market position to its competitors. Analyze how Cytosorbents Crp is positioned in terms of product offerings, innovation, and market share.
- Check if Cytosorbents Crp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Cytosorbents Crp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Cytosorbents Crp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Cytosorbents Crp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Cytosorbents Crp Stock
Researching Cytosorbents Crp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 33.0% of the company shares are held by institutions such as insurance companies. The book value of Cytosorbents Crp was currently reported as 0.24. The company recorded a loss per share of 0.36. Cytosorbents Crp had not issued any dividends in recent years. The entity had 1:25 split on the 5th of December 2014.
To determine if Cytosorbents Crp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cytosorbents Crp's research are outlined below:
| Cytosorbents Crp had very high historical volatility over the last 90 days | |
| Cytosorbents Crp has some characteristics of a very speculative penny stock | |
| Cytosorbents Crp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 36.35 M. Net Loss for the year was (28.51 M) with profit before overhead, payroll, taxes, and interest of 20.73 M. | |
| Cytosorbents Crp currently holds about 30.16 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69. | |
| Cytosorbents Crp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Granahan Investment Management Reduces Stake in CytoSorbents Cor - GuruFocus.com |
Cytosorbents Crp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cytosorbents Crp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cytosorbents Crp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Cytosorbents Crp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Cytosorbents Crp's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2015-11-13 | 2015-09-30 | -0.1 | -0.11 | -0.01 | 10 | ||
2024-11-07 | 2024-09-30 | -0.06 | -0.04 | 0.02 | 33 | ||
2024-08-02 | 2024-06-30 | -0.1 | -0.08 | 0.02 | 20 | ||
2018-05-08 | 2018-03-31 | -0.12 | -0.1 | 0.02 | 16 | ||
2018-03-08 | 2017-12-31 | -0.09 | -0.11 | -0.02 | 22 | ||
2017-08-07 | 2017-06-30 | -0.06 | -0.04 | 0.02 | 33 | ||
2016-05-09 | 2016-03-31 | -0.1 | -0.08 | 0.02 | 20 | ||
2023-08-01 | 2023-06-30 | -0.11 | -0.14 | -0.03 | 27 |
Know Cytosorbents Crp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cytosorbents Crp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytosorbents Crp backward and forwards among themselves. Cytosorbents Crp's institutional investor refers to the entity that pools money to purchase Cytosorbents Crp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-06-30 | 140.3 K | Advisor Group Holdings, Inc. | 2024-06-30 | 112.4 K | Susquehanna International Group, Llp | 2024-06-30 | 89.8 K | Amh Equity Ltd | 2024-09-30 | 82.8 K | Renaissance Technologies Corp | 2024-09-30 | 79.6 K | Northern Trust Corp | 2024-09-30 | 74.9 K | Raymond James Finl Svs Advisors, Inc. | 2024-09-30 | 60.6 K | Raymond James & Associates | 2024-09-30 | 50 K | Stifel Financial Corp | 2024-06-30 | 45 K | Avenir Corporation | 2024-09-30 | 3 M | Skylands Capital, Llc | 2024-09-30 | 2.8 M |
Cytosorbents Crp's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.04 M.Market Cap |
|
Cytosorbents Crp's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.58) | (0.61) | |
| Return On Capital Employed | (0.81) | (0.77) | |
| Return On Assets | (0.54) | (0.56) | |
| Return On Equity | (1.22) | (1.16) |
Determining Cytosorbents Crp's profitability involves analyzing its financial statements and using various financial metrics to determine if Cytosorbents Crp is a good buy. For example, gross profit margin measures Cytosorbents Crp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cytosorbents Crp's profitability and make more informed investment decisions.
Evaluate Cytosorbents Crp's management efficiency
Cytosorbents Crp has return on total asset (ROA) of (0.2793) % which means that it has lost $0.2793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.185) %, meaning that it created substantial loss on money invested by shareholders. Cytosorbents Crp's management efficiency ratios could be used to measure how well Cytosorbents Crp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of December 2024, Return On Tangible Assets is likely to drop to -0.61. In addition to that, Return On Capital Employed is likely to grow to -0.77. At this time, Cytosorbents Crp's Total Assets are very stable compared to the past year. As of the 1st of December 2024, Non Current Assets Total is likely to grow to about 28.9 M, while Total Current Assets are likely to drop about 17.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.52 | 0.58 | |
| Tangible Book Value Per Share | 0.43 | 0.51 | |
| Enterprise Value Over EBITDA | (1.87) | (1.96) | |
| Price Book Value Ratio | 2.13 | 2.24 | |
| Enterprise Value Multiple | (1.87) | (1.96) | |
| Price Fair Value | 2.13 | 2.24 | |
| Enterprise Value | 53.8 M | 93.7 M |
Leadership at Cytosorbents Crp emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Beta 0.564 |
Basic technical analysis of Cytosorbents Stock
As of the 1st of December, Cytosorbents Crp shows the Mean Deviation of 4.11, downside deviation of 5.91, and Risk Adjusted Performance of 0.0238. Cytosorbents Crp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cytosorbents Crp's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cytosorbents Crp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cytosorbents Crp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cytosorbents Crp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cytosorbents Crp's Outstanding Corporate Bonds
Cytosorbents Crp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cytosorbents Crp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cytosorbents bonds can be classified according to their maturity, which is the date when Cytosorbents Crp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Cytosorbents Crp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Cytosorbents Crp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0238 | |||
| Market Risk Adjusted Performance | 0.0618 | |||
| Mean Deviation | 4.11 | |||
| Semi Deviation | 5.15 | |||
| Downside Deviation | 5.91 | |||
| Coefficient Of Variation | 5086.77 | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.79 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.92) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0518 | |||
| Maximum Drawdown | 32.59 | |||
| Value At Risk | (8.55) | |||
| Potential Upside | 9.15 | |||
| Downside Variance | 34.98 | |||
| Semi Variance | 26.57 | |||
| Expected Short fall | (5.14) | |||
| Skewness | 0.8049 | |||
| Kurtosis | 4.67 |
| Risk Adjusted Performance | 0.0238 | |||
| Market Risk Adjusted Performance | 0.0618 | |||
| Mean Deviation | 4.11 | |||
| Semi Deviation | 5.15 | |||
| Downside Deviation | 5.91 | |||
| Coefficient Of Variation | 5086.77 | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.79 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.92) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0518 | |||
| Maximum Drawdown | 32.59 | |||
| Value At Risk | (8.55) | |||
| Potential Upside | 9.15 | |||
| Downside Variance | 34.98 | |||
| Semi Variance | 26.57 | |||
| Expected Short fall | (5.14) | |||
| Skewness | 0.8049 | |||
| Kurtosis | 4.67 |
Consider Cytosorbents Crp's intraday indicators
Cytosorbents Crp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cytosorbents Crp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cytosorbents Crp time-series forecasting models is one of many Cytosorbents Crp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cytosorbents Crp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Cytosorbents Stock media impact
Far too much social signal, news, headlines, and media speculation about Cytosorbents Crp that are available to investors today. That information is available publicly through Cytosorbents media outlets and privately through word of mouth or via Cytosorbents internal channels. However, regardless of the origin, that massive amount of Cytosorbents data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cytosorbents Crp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cytosorbents Crp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cytosorbents Crp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cytosorbents Crp alpha.
Cytosorbents Crp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Cytosorbents Crp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cytosorbents Crp Corporate Management
| CPA CPA | CFO Sec | Profile | |
| Robert MD | CoChairman Consultant | Profile | |
| MS MS | Pres COO | Profile | |
| Christian MD | Executive Marketing | Profile | |
| MS MBA | Senior Development | Profile | |
| Terri MBA | Vice Communications | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share 0.72 | Quarterly Revenue Growth 0.066 | Return On Assets (0.28) | Return On Equity (1.19) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Cytosorbents Crp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.